Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M13.9Revenue $M5.0Net Margin (%)-424.0Altman Z-Score-47.4
Enterprise Value $M27.3EPS $-1.1Operating Margin %-796.3Piotroski F-Score2
P/E(ttm)--Beneish M-Score-10.4Pre-tax Margin (%)-424.0Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio0.2Cash flow > EarningsN
Price/Sales2.55-y EBITDA Growth Rate %--Current Ratio0.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-59.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M21.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ALXA

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ALXA is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ALXA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Grupo Ferrer Internacional, S.10% Owner 2014-10-27Sell0$0view
Kamemoto Edwin SSVP, Regulatory Affairs 2014-06-27Sell0$0view
RINGOLD GORDONDirector 2013-09-06Buy10,000$4.77-86.58view
KING THOMAS BRAXTONPres & CEO 2013-07-26Buy40,000$4.48-85.71view
KING THOMAS BRAXTONPres & CEO 2013-07-26Buy40,000$4.48-85.71view
LANSDOWNE PARTNERS AUSTRIA GMB10% Owner 2013-01-18Sell125,000$4.75-86.53view
LANSDOWNE PARTNERS AUSTRIA GMB10% Owner 2012-12-27Buy72,189$4.85-86.8view
Cassella James VEVP, R&D and CSO 2012-12-26Sell4,558$4.9-86.94view
Simms Michael JSVP, Operations & Manuf 2012-12-26Sell4,558$4.9-86.94view
LANSDOWNE PARTNERS AUSTRIA GMB10% Owner 2012-12-26Sell0$0-86.94view

Quarterly/Annual Reports about ALXA:

News about ALXA:

Articles On GuruFocus.com
Wrong Marketing Lesson by Big Pharma May 03 2014 
Weekly CEO Buys Highlight: RCL, PSXP, ALXA, PAY, HAFC Aug 05 2013 
Royal Caribbean and Four Others Report $100 Thousand CEO Buys Jul 31 2013 
President and CEO of Alexza Pharmaceuticals Inc. Thomas Braxton King Bought 40,000 Shares Jul 29 2013 
Weekly CEO Buys Highlight: NYLD, ALXA, DOC, NTWK, SNV Jul 29 2013 
Alexza Pharmaceuticals Inc. (ALXA) SVP, CFO & Sec August J Moretti sells 10,000 Shares May 07 2010 
Alexza Pharmaceuticals Inc. (ALXA) SVP, CFO & Sec August J Moretti sells 14,000 Shares Dec 21 2009 
Alexza Pharmaceuticals Inc. (ALXA) Pres & CEO Thomas Braxton King sells 45,000 Shares Dec 21 2009 
Weekly CEO Buy Highlight: Winmark Corp, Alexza Pharmaceuticals Inc, Ladenburg Thalmann Financial Ser Oct 11 2009 

More From Other Websites
Alexza to Report 2016 First Quarter Financial Results and Provide Corporate Update on Wednesday, May... Apr 27 2016
Alexza to Report 2016 First Quarter Financial Results and Provide Corporate Update on Wednesday, May... Apr 27 2016
ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement,... Apr 15 2016
ALEXZA PHARMACEUTICALS INC. Financials Apr 01 2016
Alexza Pharmaceuticals, Inc. :ALXA-US: Earnings Analysis: Q4, 2015 By the Numbers Mar 30 2016
Alexza Pharmaceuticals, Inc. :ALXA-US: Earnings Analysis: 2015 By the Numbers Mar 30 2016
Earnings Recap For March 28 Mar 28 2016
Alexza Reports Fourth Quarter and Year End 2015 Financial Results Mar 28 2016
ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 28 2016
Alexza Reports Fourth Quarter and Year End 2015 Financial Results Mar 28 2016
Q4 2015 Alexza Pharmaceuticals Inc Earnings Release - After Market Close Mar 28 2016
ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement,... Mar 24 2016
Alexza to Report 2015 Year End Financial Results and Provide Company Update on Monday, March 28,... Mar 15 2016
ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 09 2016
Alexza Pharmaceuticals Receives Positive Nasdaq Listing Determination Mar 09 2016
ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Feb 29 2016
Alexza Pharmaceuticals Confirms Grupo Ferrer Non-binding Letter of Intent Feb 26 2016
ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Feb 24 2016
Alexza Pharmaceuticals Reacquires U.S. Commercial Rights for ADASUVE® (loxapine) inhalation powder Feb 24 2016
ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Jan 22 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)